Cafepharma Today

June 2 2023 - Novartis drug helps stop breast cancer’s return in large study
Novartis drug helps stop breast cancer’s return in large study
Pfizer says antibiotic is effective against tough-to-treat infections
Medicare outlines plan to expand coverage for costly new Alzheimer’s drugs
Supreme Court vetoes efforts to limit anti-fraud law aimed at government contractors
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
Topas launches Phase IIa trial of celiac disease therapy
Clinical Trials Arena
Friday, May 26, 2023 - 9:52am
tags:
Topas Therapeutics, clinical trials, celiac disease, TPM502
VarmX raises funds to seek IND approval for VMX-C001
Pharmaceutical Business Review
Friday, May 26, 2023 - 9:50am
tags:
VarmX, funding, VMS-C001, anticoagulant reversal
Serial biotech founder Tim Springer on investing in startups and democratizing antibody research
BioPharma Dive
Friday, May 26, 2023 - 9:47am
tags:
Tim Springer, Harvard, biotech, R&D
Science finally figured out how to make effective RSV vaccines. Will seniors care?
Stat
Friday, May 26, 2023 - 9:46am
tags:
RSV, vaccines, elderly, Pfizer, GSK
ASCO puts spotlight on advancing antibody-drug conjugate pipeline
BioPharma Dive
Thursday, May 25, 2023 - 8:51pm
tags:
ASCO 2023, antibody-drug conjugate, Merck, BioNTech, Daiichi Sankyo
ASCO: Regeneron's Opdualag rival records double the historical response rate in melanoma
Fierce Biotech
Thursday, May 25, 2023 - 8:49pm
tags:
ASCO 2023, Regeneron, advanced melanoma, fianlimab
Lilly steps up its oral obesity push
EP Vantage
Thursday, May 25, 2023 - 8:45pm
tags:
Eli Lilly, obesity, GLP-1 agonist, orforglipron
ASCO: Merck gives final look at Keytruda study in first-line cervical cancer. Will FDA change its mind?
Fierce Pharma
Thursday, May 25, 2023 - 8:37pm
tags:
ASCO 2023, Merck, Keytruda, cervical cancer
ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers
Fierce Pharma
Thursday, May 25, 2023 - 8:33pm
tags:
ASCO 2023, Merck, Keytruda, Novartis, Kisqali, non-small cell lung cancer, early breast cancer
Bristol Myers data make case for earlier use of bone marrow disease drug
BioPharma Dive
Thursday, May 25, 2023 - 8:31pm
tags:
Bristol Myers Squibb, Reblozyl, Epogen, myelodysplastic syndromes, clinical trials
More Layoffs Signal COVID-19 Testing Boom Is Over
Medical Devices and Diagnostics Industry
Thursday, May 25, 2023 - 8:29pm
tags:
Abbott Labs, layoffs, Medtech, diagnostics, COVID-19
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
CNBC
Thursday, May 25, 2023 - 8:28pm
tags:
Pfizer, Paxlovid, COVID-19, FDA, antivirals
Annexon reports topline results from Phase II trial of geographic atrophy therapy
Clinical Trials Arena
Thursday, May 25, 2023 - 8:25pm
tags:
Annexon, clinical trials, ANX007, vision loss, geographic atrophy
Biopharma staffers exhausted and susceptible to burnout, report says
Fierce Pharma
Thursday, May 25, 2023 - 1:18pm
tags:
pharma employees, burnout
Apellis abandons ALS drug after study miss
BioPharma Dive
Thursday, May 25, 2023 - 1:16pm
tags:
Apellis Pharmaceuticals, ALS, clinical trials, pegcetacoplan
Medicaid plans to audit the prices of costliest drugs
ABC News
Thursday, May 25, 2023 - 1:15pm
tags:
White House, drug pricing, Medicaid, CMS
House lawmakers, PBM lobby spar over committee hearing
BioPharma Dive
Thursday, May 25, 2023 - 1:11pm
tags:
PBMs, legislation, drug pricing
After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California
Fierce Pharma
Thursday, May 25, 2023 - 1:10pm
tags:
Gilead Sciences, Teva Pharmaceutical, legal, HIV, antitrust
After breakup with Otsuka, Akebia finds new partner for oral anemia drug in Europe
Fierce Pharma
Thursday, May 25, 2023 - 1:07pm
tags:
Akebia Therapeutics, Medice Arzneimittel Pütter, Europe, Australia, Vafseo, chronic kidney disease
BenevolentAI Cuts Workforce, Pipeline in Strategic Realignment
BioSpace
Thursday, May 25, 2023 - 12:52pm
tags:
BenevolentAI, layoffs

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

The Drug Discount Ecosystem’s “Mission Critical”
Drug Channels
Fakin' It the Modern Way
In the Pipeline
Reduction of Tau
In the Pipeline
Timeless
In the Pipeline
Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G
Drug Channels
AI and the Hard Stuff
In the Pipeline
Break Out the Purple Carrots
In the Pipeline
Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations
Drug Channels
Give Me Those Hard, Hard Numbers
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information